Opioid use during pregnancy: An analysis of comment data from the 2016 Pregnancy Risk Assessment Monitoring System survey

References

• U.S. Department of Health & Human Services. HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis. 2017. https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html. Published October 26, 2017. Accessed August 8, 2019.
   Google Scholar
• Leech AA, Cooper WO, McNeer E, Scott TA, Patrick SW. Neonatal abstinence syndrome in the United States, 2004–16. Health Aff. 2020;39(5):764–767.
   Web of Science ®Google Scholar
• Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths – United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290–297.
   PubMed Web of Science ®Google Scholar
• Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization – United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845–849.
   PubMed Web of Science ®Google Scholar
• Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid. Pediatrics. 2018;141(4):e20173520–2014.
   PubMed Web of Science ®Google Scholar
• Strahan AE, Guy GP, Jr., Bohm M, Frey M, Ko JY. Neonatal abstinence syndrome incidence and health care costs in the United States. JAMA Pediatr. 2020;174(2):200.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. America’s drug overdose epidemic: putting data to action; 2020. https://www.cdc.gov/injury/features/prescription-drug-overdose/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fopioids%2Fstrategy.html. Accessed August 8, 2019.
   Google Scholar
• Ko JY, D'Angelo DV, Haight SC, et al. Vital signs: prescription opioid pain reliever use during pregnancy – 34 U.S. Jurisdictions, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(28):897–903.
   PubMed Web of Science ®Google Scholar
• Goodman DJ, Saunders EC, Wolff KB. In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders. BMC Pregnancy Childbirth. 2020;20(1):178.
   PubMed Web of Science ®Google Scholar
• Mburu G, Ayon S, Mahinda S, Kaveh K. Determinants of women's drug use during pregnancy: perspectives from a qualitative study. Matern Child Health J. 2020;24(9):1170–1178.
   PubMed Web of Science ®Google Scholar
• Shulman HB, D'Angelo DV, Harrison L, Smith RA, Warner L. The Pregnancy Risk Assessment Monitoring System (PRAMS): overview of design and methodology. Am J Public Health. 2018;108(10):1305–1313.
   PubMed Web of Science ®Google Scholar
• O'Cathain A, Thomas KJ. "Any other comments?" Open questions on questionnaires – a bane or a bonus to research? BMC Med Res Methodol. 2004;4:25.
   PubMedGoogle Scholar
• Kanotra S, D'Angelo D, Phares TM, Morrow B, Barfield WD, Lansky A. Challenges faced by new mothers in the early postpartum period: an analysis of comment data from the 2000 Pregnancy Risk Assessment Monitoring System (PRAMS) survey. Matern Child Health J. 2007;11(6):549–558.
   PubMed Web of Science ®Google Scholar
• Hotham ED, Ali RL, White JM. Analysis of qualitative data from the investigation study in pregnancy of the ASSIST Version 3.0 (the Alcohol, Smoking and Substance Involvement Screening Test). Midwifery. 2016;34:183–197.
   PubMed Web of Science ®Google Scholar
• Meyer JP, Isaacs K, El-Shahawy O, Burlew AK, Wechsberg W. Research on women with substance use disorders: Reviewing progress and developing a research and implementation roadmap. Drug Alcohol Depend. 2019;197:158–163.
   PubMed Web of Science ®Google Scholar
• Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288.
   PubMed Web of Science ®Google Scholar
• Metz VE, Brown QL, Martins SS, Palamar JJ. Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use. Drug Alcohol Depend. 2018;183:261–266.
   PubMed Web of Science ®Google Scholar
• Peeler M, Gupta M, Melvin P, et al. Racial and ethnic disparities in maternal and infant outcomes among opioid-exposed mother-infant dyads in Massachusetts (2017–2019). Am J Public Health. 2020;110(12):1828–1836.
   PubMed Web of Science ®Google Scholar
• Rawson RA, Rieckmann T, Cousins S, McCann M, Pearce R. Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system. Prev Med. 2019;128:105785.
   PubMed Web of Science ®Google Scholar
• Sokol R, Albanese C, Chaponis D, et al. Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study. Subst Abus. 2018;39(1):52–58.
   PubMed Web of Science ®Google Scholar
• O' Leary K, Dockray S, Hammond S. Positive prenatal well-being: conceptualising and measuring mindfulness and gratitude in pregnancy. Arch Womens Ment Health. 2016;19(4):665–673.
   PubMed Web of Science ®Google Scholar
• Leung CC, Tong EMW. Gratitude and drug misuse: role of coping as mediator. Subst Use Misuse. 2017;52(14):1832–1839.
   PubMed Web of Science ®Google Scholar
• Millstein RA, Celano CM, Beale EE, et al. The effects of optimism and gratitude on adherence, functioning and mental health following an acute coronary syndrome. Gen Hosp Psychiatry. 2016;43:17–22.
   PubMed Web of Science ®Google Scholar
• Substance abuse in pregnancy. ACOG technical bulletin number 195–July 1994 (replaces No. 96, September 1986). Int J Gynaecol Obstet. 1994;47(1):73–80.
   PubMed Web of Science ®Google Scholar
• Ko JY, Tong VT, Haight SC, et al. Obstetrician-gynecologists' practices and attitudes on substance use screening during pregnancy. J Perinatol. 2020;40(3):422–432.
   PubMed Web of Science ®Google Scholar
• Henderson ZT, Ernst K, Simpson KR, et al. The national network of state perinatal quality collaboratives: a growing movement to improve maternal and infant health. J Womens Health. 2018;27(2):123–127.
   Web of Science ®Google Scholar
• Kroelinger CD, Rice ME, Cox S, et al. State strategies to address opioid use disorder among pregnant and postpartum women and infants prenatally exposed to substances, including infants with neonatal abstinence syndrome. MMWR Morb Mortal Wkly Rep. 2019;68(36):777–783.
   PubMed Web of Science ®Google Scholar
• Elms N, Link K, Newman A, Brogly SB, Kingston House of Recovery for Women and Children. Need for women-centered treatment for substance use disorders: results from focus group discussions. Harm Reduct J. 2018;15(1):40.
   PubMedGoogle Scholar
• Fowler C, Reid S, Minnis J, Day C. Experiences of mothers with substance dependence: Informing the development of parenting support. J Clin Nurs. 2014;23(19–20):2835–2843.
   PubMed Web of Science ®Google Scholar
• Frazer Z, McConnell K, Jansson LM. Treatment for substance use disorders in pregnant women: motivators and barriers. Drug Alcohol Depend. 2019;205:107652.
   PubMed Web of Science ®Google Scholar
• Gartner K, Elliott K, Smith M, Pearson H, Hunt G, Martin RE. People in regular society don't think you can be a good mother and have a substance use problem": participatory action research with women with substance use in pregnancy. Can Fam Physician. 2018;64(7):e309–e316.
   PubMedGoogle Scholar
• Alexander K. A call for compassionate care. J Addict Nurs. 2017;28(4):220–223.
   PubMed Web of Science ®Google Scholar
• van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.
   PubMed Web of Science ®Google Scholar
• Lemon LS, Caritis SN, Venkataramanan R, Platt RW, Bodnar LM. Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome. Epidemiology. 2018;29(2):261–268.
   PubMed Web of Science ®Google Scholar
• Klaman SL, Isaacs K, Leopold A, et al. Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance. J Addict Med. 2017;11(3):178–190.
   PubMed Web of Science ®Google Scholar
• Ko JY, Wolicki S, Barfield WD, et al. CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome. MMWR Morb Mortal Wkly Rep. 2017;66(9):242–245.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019.
   Google Scholar
• Leiner C, Cody T, Mullins N, Ramage M, Ostrach BMM. "The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia. BMC Pregnancy Childbirth. 2021;21(1):143.
   PubMed Web of Science ®Google Scholar